Aristides Capital’s Picard Medical PMI Stock Holding History

Aristides Capital’s Portfolio PMI Stock Details PMI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-67,312	Closed	-$118K	–	307
2025 Q4	$118K	Buy	+67,312	New	+$317K	0.02%	251

Other funds holding PMI

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

WMP

Wealth Management Partners Tucson, Arizona $350M AUM 39.2% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

GSC

Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Aristides Capital's PMI Position: Q1 2026 in Review

Aristides Capital sold out of Picard Medical (PMI) in Q1 2026, closing a stake of 67,312 shares — an estimated $118K sold.

Aristides Capital first reported a position in PMI in Q4 2025 and held it in 1 quarter. The position peaked at $118K in Q4 2025. 41 funds tracked by Wall St. Rank hold PMI as of Q1 2026.

Aristides Capital reported no remaining Picard Medical position as of Q1 2026 after selling out during the quarter.
Aristides Capital sold 67,312 Picard Medical shares in Q1 2026, an estimated $118K.
Aristides Capital first reported a position in Picard Medical in Q4 2025 and held it in 1 quarter.
Aristides Capital's Picard Medical position peaked at $118K in Q4 2025.
41 funds tracked by Wall St. Rank held Picard Medical as of Q1 2026.

Based on Aristides Capital's 13F filing for Q1 2026, filed 14 May 2026.